Given the interactions between MAPK signaling and ERα in ovarian cancer, we hypothesized that deregulation of MAPK modulates the intrinsic activity of ERα, and contributes to endocrine resistance in EOC. This evidence concerns the gene ESR1 and ovarian carcinoma.